Corient Private Wealth
HALO icon

Corient Private Wealth’s Halozyme HALO Stock Holding History

Corient Private Wealth’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3M Sell
190,684
-202,245
-51% -$14.3M 0.02% 549
2025
Q4 		$26.4M Buy
392,929
+381,048
+3,207% +$25.6M 0.02% 501
2025
Q3 		$871K Buy
11,881
+3,851
+48% +$256K ﹤0.01% 1495
2025
Q2 		$418K Sell
8,030
-1,769
-18% -$101K ﹤0.01% 1795
2025
Q1 		$625K Buy
9,799
+4,020
+70% +$234K ﹤0.01% 1493
2024
Q4 		$276K Sell
5,779
-14,464
-71% -$742K ﹤0.01% 1941
2024
Q3 		$1.16M Sell
20,243
-7,410
-27% -$425K ﹤0.01% 1336
2024
Q2 		$1.45M Buy
27,653
+5,636
+26% +$247K ﹤0.01% 1178
2024
Q1 		$896K Buy
22,017
+136
+0.6% +$5.1K ﹤0.01% 1347
2023
Q4 		$809K Buy
21,881
+3,206
+17% +$121K ﹤0.01% 1376
2023
Q3 		$713K Buy
18,675
+2,075
+13% +$85K ﹤0.01% 1310
2023
Q2 		$599K Buy
+16,600
New +$566K ﹤0.01% 1368
2023
Q1 		– Sell
-4,976
Closed -$283K – 2030
2022
Q4 		$283K Buy
+4,976
New +$255K ﹤0.01% 1361

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth's HALO Position: Q1 2026 in Review

Corient Private Wealth reduced its Halozyme (HALO) stake by 51% in Q1 2026, selling an estimated $14.3M and leaving 190,684 shares worth $12.3M. The position accounts for 0.02% of the portfolio, ranked #549.

Corient Private Wealth first reported a position in HALO in Q4 2022 and has held it in 13 quarters since. The position peaked at $26.4M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Corient Private Wealth held 190,684 shares of Halozyme worth $12.3M as of Q1 2026.
  • Corient Private Wealth sold 202,245 Halozyme shares in Q1 2026, an estimated $14.3M.
  • Halozyme made up 0.02% of Corient Private Wealth's portfolio in Q1 2026, its #549 holding.
  • Corient Private Wealth first reported a position in Halozyme in Q4 2022 and has held it in 13 quarters since.
  • Corient Private Wealth's Halozyme position peaked at $26.4M in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.